Professional Documents
Culture Documents
Proteus Toxic Agglutinin, A Novel: Autotransported Cytotoxin With No Bacterial Homologs
Proteus Toxic Agglutinin, A Novel: Autotransported Cytotoxin With No Bacterial Homologs
Praveen Alamuri
Mobley Lab
812 Seminar
Outline
• Proteus mirabilis and complicated urinary tract infections
• Autotransporter proteins
• 2 x 0.5 µM in size
• Dimorphic
• Opportunistic uropathogen
• Efficient biofilms
http://141.150.157.117:8080/pro www.bhrgroup.co.uk
kPUB/chaphtm/333/01_00.htm
Proteus Complicated Urinary Tract Infections
• Long-term catheterization
• Polymicrobial infections
www.cardiff.ac.uk/.../micro/pics/djs3.jpg
Pathogenesis of Proteus Infections
Ascending urinary tract infection Established virulence factors
bacteremia
pyelonephritis
?
Hemolysin IgA-protease
?
Urease
Fe2+
Flagella
cystitis Fimbriae
Irreversible tissue damage
• In pathogenic Gram-negatives
β OM • Surface expressed proteins
C
N
C
• Long signal sequence
PP
• N-terminal alpha: trait / function
Sec-system
• C-terminal beta: translocation
IM
Adhesion
Autogglutination and
biofilm
N 9 anti-parallel C
β sheets
Pta
P. mirabilis
His 147
Goals:
• Determine the function of Pta in E. coli
• Characterize passenger domain
• Assign a role for Pta in P. mirabilis
• Test its efficacy as a vaccine
Various Forms of Pta Used in this Study
α β
Pta-α
N C
Ni++-NTA–Imidazole
25
20
On-column
refolding and elution
Interaction of E. coli-Pta with Hep2
E. coli Hep2
Evidence of Evidence of
cytotoxicity autoaggregation 100X; Bar=100 µm
Quantitative estimation of cell lysis
Cytotox-one Membrane integrity assay
Leaky cell
LDH
LDH
Lactate Pyruvate
NAD+ NADH
Resorufin Resazurin
100 8 µg/ml
% Maximum Lysis
6 µg/ml
80
4 µg/ml
60
2 µg/ml
40
Pta *
20
8 µg/ml
0
0 30 60 90 120
Minutes
Pta 8 µg/ml
Pta *:
8 µg/ml - 120 mins
60X ; Bar=100 µM
• Membrane-associated 110 kDa AT
• Indication of cytotoxicity and agglutination
hydrolyzed/min/mg protein
PTA
[s] = 100 uM 10
PTA (S366A)
mol substrate
[E] = 20 nM 8 PTA (H147A)
PTA -PMSF
HEPES 6 Buffer
buffer pH 8.0 4
20 mM Ca2+ **
2
0
S1 S2 S3
Substrate
S1 = N-Suc-Ala-Ala-Pro-Phe-
pNa Chymotrypsin-like
S2 = N-Suc-Ala-Ala-Pro-Leu-pNa
S3 = N-Suc-Ala-Ala-Pro-Lys-pNa Trypsin-like
Pta is an Alkaline Protease
S1 = 100 µM
Pta-α = 20 nM
Pta-α pre-incubated
at various pH
S1 = 25 - 150 µM
Pta-α = 20 nM 0.087
1/ v
pH = 8.5
KM = 22 µM - 0.045
1/[s]
Pta is a Subtilisin-like Alkaline Protease
20 nM Pta-α 100 µM S1 Protease activity
estimated
Incubated with pH 8.5
inhibitor
Inhibitor % Inhibition
PMSF 90
Serine protease
DFP 95
TLCK 0
TPCK 25 Non-trypsin like
STI 80
BBI 75 Subtilisin-like
Chymostatin 90
Subtilisin-like
Leupeptin 100
Cytotoxicity Attributed to Protease Activity
37 ºC; 2 hrs Quantify
LDH
release in
Purified Pta-α Cultured host culture
8 µg/ml cells supernatant
120 ** PTA
** PTA *
% Maximum Lysis
100 PMSF-Treated
(PTA ) **, P<0.01
80
60
40
20
0
HEK293 UMUC-3 VERO BHK21 MMK.5
Cell Line
Actin and Nuclear Damage by Pta
Phalloidin DAPI Merge
PBS
Vero Cell
Monolayer
Pta-α
Pta-α 8 µg/ml
for 45 mins
PBS
Treated
Pta
8 µg/mL
for 4 hrs
100X; Bar=100 µM
• Pta is a 110 kDa subtilisin-like alkaline protease AT
• Cell surface-associated cytotoxin
• Function associated with the passenger domain
• May be an agglutinin
P. mirabilis cultured
under different
conditions
pH
kDa M 5 9 7
Outer membrane 150
fraction collected 100
ParaC
WT pta
pta
OD600
pBAD
a
-pt
A D AD
T / pB / pB
a a a
W pt pt pt
250
Hours
150
10 bacteria
7
10 bacteria
80 **
60
40 * **
20
* P<0.05 0
** P<0.01 WT WT/ pta - pta- / pta-/
pBAD-pta pBAD-pta pBAD-pta*
Pta Promotes Autoaggregation of P. mirabilis
Cells in buffer
pH 8.5 600
Autoaggregation is independent
of protease activity
Autoaggregation
Mutant Attenuated in Kidney and Spleen
Independent Challenge WT HI4320 pta - N=10
WT pta
P=0.10 P=0.06 P=0.007 P=0.03
10
5 x 10 CFU Log10 CFU/g tissue or ml
7
urine 8
4
Plate
2
homogenates
after 7 days 0
Urine Bladder Kidney Spleen
Role for Pta in Virulence
Host cell
membrane
disruption
Host cell
lysis
Pta as a Vaccine Against P. mirabilis
• Surface exposed
Intranasal Immunization
Days 0 7 14 21 28
Immunize Boost Challenge Sacrifice
50 µg Pta*+ 5 µg CT 25 µg Pta*+ 5 µg CT 5x107 CFU
5 µg CT 5 µg CT P. mirabilis
N = 10
1° = 50 µg
Boost = 20 µg
Future Directions
• ELISA IgG, IgM, IgA
• Try IV or IP Route
• Continue with Pta-α
P<0.0001
Measure at A405 N=6
P<0.01
Goat
Anti-Mouse
Ig-AP
Pre- or Post
Immune Sera
P=0.03
Pta Binding
Hemolysin IgA-protease
Urease Fe 2+
Acquisition
Flagella
Fimbriae
Pta
Adhesion
Autoagglutination
Cytotoxic
Serum resistance
Hemagglutination
Stephanie Himpsl
Sara Smith
Freaked out
www.promega.com
HeLa Infected with Pta
Buffer + 0.20 % ZW Buffer + 0.35 % ZW
10
HI3420
Log10 CFU/ml
8
6 pta
4
Co culture
2
0
1 2 3 4 5 6 7 8 9 10 11
Hours
Wild-type Out-competes pta Strain in vivo
P=0.13 P=0.02 P=0.0023 P=0.0018
WT : pta
1 1
5 x 107 CFU
Plate
homogenates
Urine Bladder Kidney Spleen
after 7 days
Goals of the Study
Cytotoxic protease
Surface adhesin
Hydrophilic loop
75
Swim Swarm
WT
pta
Urolithiasis: Hallmark of Proteus Infections
pH
Urea NH4+ +
HCO3
NH3 +
Urease CO2
Stones in an infected
mouse bladder
Pta
P. mirabilis
Nielubowicz and Mobley
Immunization with Pta
Offers Moderate Protection
N=12
Catheterization aggravates
urolithiasis